Isleworth Healthcare Acquisition Corp.
ISLEW
NASDAQ Capital Market0.00
USD
- -
- -
CIK
0001837997
Return %
Stock
S&P500
1Y
- -
26.53
3Y
-98.73
76.60
5Y
-99.61
80.11
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Robert S. Whitehead
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 970 Lake Carillon Drive St. Petersburg FL United States of America
- IPO Date
- Mar 29, 2021
- CIK
- 0001837997
- Similar Companies
- Business
- Isleworth Healthcare Acquisition Corp. operated as a special purpose acquisition company, formed with the intention of executing a business combination such as a merger, asset acquisition, or similar transaction with a target enterprise. Established in 2020 and headquartered in St. Petersburg, Florida, its primary focus was identifying a suitable partner within the biopharmaceutical or medical technology sectors. Although it initially entered into a definitive merger agreement with Cytovia Holdings, Inc. in April 2022, this proposed combination was mutually terminated by June of the same year. Consequently, the company announced its decision in August 2022 to liquidate its trust and redeem its shares, ceasing all operations by the end of that month.